NCT04888819View on ClinicalTrials.gov

Treatment Effect According to Timing of Administration of DWP14012 40 mg

NAUnknownINTERVENTIONAL
Enrollment

186

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

July 31, 2021

Study Completion Date

December 31, 2021

Conditions
Erosive Esophagitis
Interventions
DRUG

DWP14012

DWP14012 40 mg, orally, once daily just after a meal up to 4 weeks

DRUG

DWP14012

DWP14012 40 mg, orally, once daily before a meal up to 4 weeks

Trial Locations (1)

Unknown

RECRUITING

Konkuk University Medical Center, Seoul

Sponsors
All Listed Sponsors
collaborator

Daewoong Pharmaceutical Co. LTD.

INDUSTRY

lead

Konkuk University Medical Center

OTHER